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Dr Bottio: The patient was a 51-year-old man presenting to a local emergency
department in January 2003 with sinus node tachycardia, chest pain, and dyspnea.
Laboratory data and arterial blood gas analyses were within normal values. The
electrocardiogram demonstrated tachycardia (105 beats/min), left ventricular hyper-
trophy, and Q-waves in the anterior leads that were hypertrophy related. He had a
chest radiograph that demonstrated a mediastinal abnormality with pleuropericardial
effusion. Cardiac physical examination was unremarkable, as was his medical
history. The hematologic and biochemical values were within normal limits. Trans-
thoracic echocardiography, computed tomography (CT), and magnetic resonance
imaging (MRI) were performed. Perhaps we could ask Dr Montisci to comment on
transthoracic echocardiography.
Dr Montisci: Two-dimensional echocardiography showed a mildly enlarged
aortic root (38 mm). Doppler scanning showed normal cardiac valve apparatuses.
The left atrial chamber was compressed by an intrapericardial mass, without signs
of discontinuity from the myocardial wall. The left and right ventricular chambers
were normal in size and function. The right atrium was encircled and compressed by
the mass, and the superior and inferior venae cavae were dilated. Only the right
superior pulmonary vena cava was detectable at echocardiography.
Dr Bottio: Dr Corbetti, would you describe CT and MRI?
Dr Corbetti: The CT scan revealed an extensive mass growing into the pericar-
dium and left thorax. The MRI is remarkable for an intrapericardial mass, probably
originating from the pericardium. It is mostly homogeneous, except for the presence
of some small cystic areas, and it grows deeply in the pericardial cavity at the back
of the heart. The major diameter of the mass is 18 cm. The heart is dislocated up and
forward (Figure 1). The heart is totally encircled by the mass; the left and right atrial
chambers are compressed, and the pulmonary veins are tightened (Figure 2).
Apparently the myocardium is not infiltrated by the mass. At MRI scanning, the
inferior pulmonary lobe of the left lung is atelectasic, and a left pleural effusion is
also present; also, the inferior vena cava is encapsulated (Figure 3). There are mildly
enlarged (8- to 9-mm) lymph nodes in the peritracheal, tracheobronchial, and
periaortic positions.
Dr Bottio: A percutaneous needle biopsy of the mass was performed to char-
acterize the mass. Dr Ninfo, would you describe the histology of the lesion?
Dr Ninfo: The histology showed fusiform cells with evident signs of several
mitoses distributed within areas with different grades of cellularity. The first
hypothesis was for a malignant lesion from peripheral nerve sheaths.
Dr Bottio: The patient underwent an extensive workup that included a total body
CT scan, the results of which were unremarkable, and a skeleton scintigraphy, which
showed signs of hypercaptation within the body of the sternum. He also underwent
an esophageal gastric duodenoscopy, which showed an extrinsic compression at the
vascular Surgery ● July 2005
Bottio and Gerosa Clinical-Pathologic Conferencemedium third of the esophagus. Bronchoscopy revealed
compression and stenosis of the left main bronchus. The CT
scan and MRI of the brain were unremarkable. Angiography
showed increased mean right atrial pressure (16 mm Hg)
and a systolic pulmonary pressure of 46 mm Hg. The right
pulmonary artery was enlarged, whereas the left was ste-
nosed. The superior left pulmonary vein was not detectable,
whereas the inferior was compressed. Both the caval veins
were dilated. The coronary arteries were normal, without
the appearance of atherosclerotic disease.
Dr Gerosa: At the time of diagnosis, the tumor was
widespread over the heart and within the pericardium, and
therefore curative excision was unexpected. The major in-
tent of our therapy was a palliation of symptoms relieving
the congestive heart failure, with perhaps a prolongation of
survival. Our aim was also to complete the surgical excision
with radiation therapy, chemotherapy, or both. At the time
of the operation, the tumor was found to be completely
welded to the myocardium because the margins of excision
could not be identified (Figure 4). It was extended toward
the left pulmonary veins, involving extensively the anterior
wall of the heart. A wide excision extending to the entry of
the left pulmonary veins was accomplished, but a large part
of the posterior mass was unresectable. The patient had a
complicated postoperative intensive care unit stay requiring
a high dose of inotropic medications and intra-aortic balloon
Figure 1. Sagittal MRI showing the tumor mass (§) compressing
the heart. # Left ventricle; * right ventricular outflow; °aorta.pump support.
The Journal of ThoraciDr Ninfo: Pathologic examination revealed a tumor
mass of 2200 g in weight in which the cut surface was
mostly solid with a grey-white appearance. Microscopi-
cally, the margins of resection were not tumor free, and it
consisted of central fibrotic areas and peripheral high-
density cellular areas in which several mitotic phenomena
were present. Immunohistochemical stains were performed,
and monoclonal antibodies against smooth muscle actin,
CD34, CD56, desmin, vimentin, calretinin, and S-100 pro-
tein were applied. The tumor tested positive for CD56 and
vimentin. The tumor was classified as a malignant periph-
eral nerve sheath sarcoma.
Dr Gerosa: In light of the definitive diagnosis and the
extreme difficulties during the surgical resection, to obtain a
complete resection of the tumor, we scheduled chemother-
apeutic treatment soon after the operation. Unfortunately,
the postoperative cardiac performance of the patient did not
allow any adjunctive treatment because of the potential
cardiotoxicity of both radiotherapy and chemotherapy.
Therefore the patient was discharged to home to wait for
cardiac recovery, when he suddenly died in the second
postoperative month.
Dr Bottio: This case is indeed not so common and
thereby offers the chance to highlight the difficulty of treat-
ment of patients affected by such dismal diseases. Primary
cardiac tumors are rare clinical entities, and fortunately,
most are benign and resectable; among these, atrial myxoma
Figure 2. Axial CT view showing the tumor mass (§) compressing
the left bronchus and pulmonary veins. * Left and right bronchus;
# left pulmonary veins.is the most common.1 On the other hand, malignant primary
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heart and pericardium, are usually widespread at diagnosis,
and because of invasion of the underlying myocardium,
their surgical resection is seldom achieved; with curative
excision being unexpected, the treatment is limited to be
only palliative. Therefore the prognosis for patients with
such cardiac tumors is poor and usually less than 12
months.2 Nerve sheath neoplasms of the heart (soft-tissue
sarcomas) are extremely rare, although they have been
reported.3 These tumors more commonly involve adults
than infants,4 and their proximity to target structures deter-
mines a subtle and nonspecific clinical presentation.5 Usu-
ally, presenting symptoms are dyspnea, pain, or shortness of
breath, which are mostly related to pericardial effusion
(often hemorrhagic), syncope, and/or sudden death when in
Figure 4. Intraoperative view of the tumor mass during thoracot-
omy. The tumor is widespread to the entire anterior wall of the
heart.Figure 3. Coronal magnetic resonance view showing the inva-
sion of the left hemithorax by the mass (§) causing a left lung
atelectasis (^). The heart chambers and the abdominal organs are
severely compressed by the tumor. The ascending aorta appears
normal, whereas the pulmonary artery trunk is enlarged. The
inferior vena cava (@) is encircled by the mass. * Left atrium;
# left ventricle; °ascending aorta; ^ Left and right lungs.the presence of tamponade, chest pain, hemoptysis, and
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the cardiac chambers, and also, the cardiac function might
worsen, leading to intractable cardiac failure. When the
hepatic veins or the vena cava are obstructed, signs of
systemic congestion appear. This is the motif that explains
the variety of clinical signs and symptoms related to such
tumors, which are often disguised as other more common
systemic diseases. The objective of surgical therapy should
be a complete resection, followed by cardiac reconstruc-
tion8,9; this is usually achieved with benign schwannomas,
which are encapsulated and well demarcated. On the con-
trary, with malignant lesions, a complete resection of the
mass is seldom achieved. Hypothetically, orthotopic heart
transplantation could allow complete resection of cardiac
tumors. Therefore cardiac transplantation,10 autotransplan-
tation when feasible,11 or both have been proposed to allow
the excision of cardiac malignancy. Obviously, a careful
preoperative assessment is necessary to determine whether
other cardiac and noncardiac structures are involved. Nev-
ertheless, with experience with cardiac transplantation for
primary cardiac neoplasms being limited, with it being
difficult to determine the tumor operability preoperatively,
and with worldwide organ availability being insufficient,
cardiac transplantation leads to many unresolved questions,
mostly focusing on the avoidance of wasting of a donor
heart. However, for these reasons and because of the high
risk of tumor recurrence or metastasis during treatment with
immunosuppressive drugs,12 the majority of patients af-
fected do not undergo transplantation. Our patient was re-
ferred to us when he had advanced disease.13 Thus a partial
excision of the cardiac tumor, followed by adjuvant radia-
tion therapy, chemotherapy, or both, should have been a
The Journal of Thoracipalliative option. Unfortunately, survival was not prolonged
because this patient suddenly died soon after discharge.
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